Literature DB >> 28649004

MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers.

Harikrishnan Radhakrishnan1, Katharina Ilm2, Wolfgang Walther2, Senji Shirasawa3, Takehiko Sasazuki4, Peter T Daniel5, Bernhard Gillissen5, Ulrike Stein6.   

Abstract

MACC1 was identified as a novel player in cancer progression and metastasis, but its role in death receptor-mediated apoptosis is still unexplored. We show that MACC1 knockdown sensitizes cancer cells to death receptor-mediated apoptosis. For the first time, we provide evidence for STAT signaling as a MACC1 target. MACC1 knockdown drastically reduced STAT1/3 activating phosphorylation, thereby regulating the expression of its apoptosis targets Mcl-1 and Fas. STAT signaling inhibition by the JAK1/2 inhibitor ruxolitinib mimicked MACC1 knockdown-mediated molecular signatures and apoptosis sensitization to Fas activation. Despite the increased Fas expression, the reduced Mcl-1 expression was instrumental in apoptosis sensitization. This reduced Mcl-1-mediated apoptosis sensitization was Bax and Bak dependent. MACC1 knockdown also increased TRAIL-induced apoptosis. MACC1 overexpression enhanced STAT1/3 phosphorylation and increased Mcl-1 expression, which was abrogated by ruxolitinib. The central role of Mcl-1 was strengthened by the resistance of Mcl-1 overexpressing cells to apoptosis induction. The clinical relevance of Mcl-1 regulation by MACC1 was supported by their positive expression correlation in patient-derived tumors. Altogether, we reveal a novel death receptor-mediated apoptosis regulatory mechanism by MACC1 in solid cancers through modulation of the STAT1/3-Mcl-1 axis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bcl-2 family proteins; Fas mediated apoptosis; MACC1; STAT signaling; Solid cancers

Mesh:

Substances:

Year:  2017        PMID: 28649004     DOI: 10.1016/j.canlet.2017.06.020

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Targeting the JAK/STAT pathway in solid tumors.

Authors:  Zoya Qureshy; Daniel E Johnson; Jennifer R Grandis
Journal:  J Cancer Metastasis Treat       Date:  2020-08-21

2.  MET transcriptional regulator/serine peptidase inhibitor kunitz type 1 panel operating through HGF/c-MET axis as a prognostic signature in pan-cancer.

Authors:  Yi Xiang; Bishan Liang; Yu Jiang; Fei Sun; Yang Zhao; Qijing Wu; Xingbin Hu; Yajing Liu; Qiong Huang; Wangjun Liao; Zhiqi Yao; Shaowei Li; Min Shi
Journal:  Cancer Med       Date:  2021-03-09       Impact factor: 4.452

3.  Insulin-like Growth Factor Binding Protein-2 (IGFBP2) Is a Key Molecule in the MACC1-Mediated Platelet Communication and Metastasis of Colorectal Cancer Cells.

Authors:  Reza Haschemi; Dennis Kobelt; Elisabeth Steinwarz; Martin Schlesinger; Ulrike Stein; Gerd Bendas
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

4.  Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker.

Authors:  Felicitas Schmid; Mathias Dahlmann; Hanna Röhrich; Dennis Kobelt; Jens Hoffmann; Susen Burock; Wolfgang Walther; Ulrike Stein
Journal:  Br J Cancer       Date:  2022-05-21       Impact factor: 9.075

5.  Oxidative Stress Activated by Sorafenib Alters the Temozolomide Sensitivity of Human Glioma Cells Through Autophagy and JAK2/STAT3-AIF Axis.

Authors:  Jianwei Wei; Zhengfeng Wang; Weiwei Wang; Xiaoge Liu; Junhu Wan; Yongjie Yuan; Xueyuan Li; Liwei Ma; Xianzhi Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-14

6.  Saffron Crudes and Compounds Restrict MACC1-Dependent Cell Proliferation and Migration of Colorectal Cancer Cells.

Authors:  Nazli Güllü; Dennis Kobelt; Hassan Brim; Shaman Rahman; Lena Timm; Janice Smith; Akbar Soleimani; Stefano Di Marco; Silvia Bisti; Hassan Ashktorab; Ulrike Stein
Journal:  Cells       Date:  2020-08-03       Impact factor: 6.600

7.  EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.

Authors:  Mengxian Tu; Lu He; Yang You; Jinying Li; Nan Yao; Chen Qu; Wei Huang; Leibo Xu; Rongcheng Luo; Jian Hong
Journal:  Cell Death Dis       Date:  2020-10-06       Impact factor: 8.469

8.  miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling.

Authors:  Xiangjie Huang; Sisi Xiao; Xinping Zhu; Yun Yu; Meng Cao; Xiaodong Zhang; Shaotang Li; Wangyu Zhu; Fengjiao Wu; Xiaohui Zheng; Libo Jin; Congying Xie; Xiaoying Huang; Peng Zou; Xiaokun Li; Ri Cui
Journal:  Cell Death Dis       Date:  2020-09-22       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.